Endoscopic Ultrasound (EUS) Features of Chronic Pancreatitis
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01442454 |
Recruitment Status
:
Terminated
(The PI left and then the PI who would be taking over has left. No other investigator wanted to take the study since not sponsored)
First Posted
: September 28, 2011
Last Update Posted
: March 1, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Chronic Pancreatitis | Other: chronic pancreatitis |
Study Type : | Observational |
Actual Enrollment : | 100 participants |
Time Perspective: | Prospective |
Official Title: | Endoscopic Ultrasound (EUS) Features of Chronic Pancreatitis: A Prospective Correlation With Intraoperative Findings and Surgical Pathology |
Study Start Date : | October 2010 |
Actual Primary Completion Date : | September 2014 |
Actual Study Completion Date : | September 2014 |

Group/Cohort | Intervention/treatment |
---|---|
Chronic Pancreatitis |
Other: chronic pancreatitis
No intervention, subjects followed through surgery
|

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Patients who are eligible are individuals who have:
- normal pancreas
- suspected chronic pancreatitis
- established chronic pancreatitis (by ERCP, MRI, previous EUS, CT)
- pancreatic cancer
Patients who are not eligible are individuals who have:
• an uncorrectable coagulopathy (platelet <50,000, INR>1.5), or bleeding disorder, or are unable to discontinue anticoagulation 5-7 days prior to EUS (aspirin and bridging therapy with lovenox are allowed, clopidogrel is not allowed)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01442454
United States, Indiana | |
Indiana University Hospital | |
Indianapolis, Indiana, United States, 46202 |
Responsible Party: | Indiana University |
ClinicalTrials.gov Identifier: | NCT01442454 History of Changes |
Other Study ID Numbers: |
1008-15 |
First Posted: | September 28, 2011 Key Record Dates |
Last Update Posted: | March 1, 2016 |
Last Verified: | February 2016 |
Keywords provided by Indiana University:
chronic pancreatitis |
Additional relevant MeSH terms:
Pancreatitis Pancreatitis, Chronic Pancreatic Diseases Digestive System Diseases |